UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma

Scientific reports, 2016-07, Vol.6 (1), p.30093-30093, Article 30093

2016

Link zum Volltext

Verfügbarkeit prüfen

Insulin-like growth factor 1 receptor and response to anti-IGF1R antibody therapy in osteosarcoma

PloS one, 2014-08, Vol.9 (8), p.e106249

2014

Link zum Volltext

Verfügbarkeit prüfen

A RUNX2-Mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells

PLoS genetics, 2016-02, Vol.12 (2), p.e1005884-e1005884

2016

Link zum Volltext

Verfügbarkeit prüfen

Down-regulation of Skp2 expression inhibits invasion and lung metastasis in osteosarcoma

Scientific reports, 2018-09, Vol.8 (1), p.14294-13, Article 14294

2018

Link zum Volltext

Verfügbarkeit prüfen

Activation of the RAF/Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase/Extracellular Signal-Regulated Kinase Pathway Mediates Apoptosis Induced by Chelerythrine in Osteosarcoma

Clinical cancer research, 2008-10, Vol.14 (20), p.6396-6404

2008

Link zum Volltext

Verfügbarkeit prüfen

Cell surface receptor expression patterns in osteosarcoma

Cancer, 2012-02, Vol.118 (3), p.740-749

2012

Link zum Volltext

Verfügbarkeit prüfen

The effect of bone morphogenetic protein-2 on osteosarcoma metastasis

PloS one, 2017-03, Vol.12 (3), p.e0173322-e0173322

2017

Link zum Volltext

Verfügbarkeit prüfen

Platelet‐derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma

Cancer, 2008-05, Vol.112 (10), p.2119-2129

2008

Link zum Volltext

Verfügbarkeit prüfen

Ganglioside GD2 as a therapeutic target for antibody‐mediated therapy in patients with osteosarcoma

Cancer, 2014-02, Vol.120 (4), p.548-554

2014

Link zum Volltext

Verfügbarkeit prüfen

Antigenic Evidence of Prevalence and Diversity of Mycobacterium tuberculosis Arabinomannan

Journal of Clinical Microbiology, 2004-07, Vol.42 (7), p.3225-3231

2004

Link zum Volltext

Verfügbarkeit prüfen

β-Catenin Does Not Confer Tumorigenicity When Introduced into Partially Transformed Human Mesenchymal Stem Cells

Sarcoma, 2012, Vol.2012, p.164803-10

2012

Link zum Volltext

Verfügbarkeit prüfen

HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival

Scientific reports, 2016-08, Vol.6 (1), p.31154-31154, Article 31154

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1418: Screening and identification of key surface markers of mesenchymal stem cell osteogenic differentiation and osteosarcoma development

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.1418-1418

2015

Link zum Volltext

Verfügbarkeit prüfen

Targeting Glycoprotein NMB With Antibody-Drug Conjugate, Glembatumumab Vedotin, for the Treatment of Osteosarcoma

Pediatric blood & cancer, 2016-01, Vol.63 (1), p.32-38

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3984: Elucidating expression patterns of GPNMB and potential anti-tumor effects of the antibody-drug conjugate, glembatumumab vedotin (CDX-011) in human osteosarcoma primary samples and cell lines

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.3984-3984

2014

Link zum Volltext

Verfügbarkeit prüfen

Detection of circulating tumor DNA in patients with osteosarcoma

Oncotarget, 2018-02, Vol.9 (16), p.12695-12704

2018

Link zum Volltext

Verfügbarkeit prüfen

Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R)

Nuclear medicine and biology, 2016-12, Vol.43 (12), p.812-817

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1630: Effects of rhBMP-2 on osteosarcoma tumorigenesis

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.1630-1630

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1412: Utilizing cell surface markers to define osteosarcoma and the stages of osteoblast differentiation

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.1412-1412

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4134: Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4134-4134

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 697: Stage 1 in vivo evaluation of multi-receptor tyrosine-kinase inhibitor lenvatinib in osteosarcoma patient derived mouse xenograft models

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.697-697

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2731: Identifying circulating tumor DNA in patients with osteosarcoma

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2731-2731

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1950: Introducing c-Myc into transformed human mesenchymal stem cells and osteoblasts to recapitulate the osteosarcoma phenotype

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1950-1950

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 920: ICAM-1(CD54) is involved in the osteogenic differentiation of mesenchymal stem cells and affects the progression of osteosarcoma cells

Cancer research (Chicago, Ill.), 2017, Vol.77 (13_Supplement), p.920-920

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1208: Elucidating possible functional implications of osteosarcoma risk-associated genetic level alterations in IGF2R

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.1208-1208

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(51)
Tagungsberichte
(1)

Sprache

Englisch
(52)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Osteosarcoma
(16)
Humans
(15)
Life Sciences & Biomedicine
(14)
Oncology
(12)
Osteosarcoma - Pathology
(12)
Animals
(9)
Cell Line, Tumor
(9)
Female
(9)
Osteosarcoma - Metabolism
(8)
Tumors
(8)
Cell Proliferation
(7)
Biological And Medical Sciences
(6)
Bone Cancer
(6)
Bone Neoplasms - Metabolism
(6)
Bone Neoplasms - Pathology
(6)
Gene Expression
(6)
Medical Sciences
(6)
Mice
(6)
Diseases Of The Osteoarticular System
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(22)
Cancer
(4)
Clinical Orthopaedics And Related Research
(3)
Pediatric Blood & Cancer
(3)
Scientific Reports
(3)
Clinical Cancer Research
(2)
Oncotarget
(2)
Plos Genetics
(2)
Plos One
(2)
Sarcoma
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma

Insulin-like growth factor 1 receptor and response to anti-IGF1R antibody therapy in osteosarcoma

A RUNX2-Mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells

Down-regulation of Skp2 expression inhibits invasion and lung metastasis in osteosarcoma

Activation of the RAF/Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase/Extracellular Signal-Regulated Kinase Pathway Mediates Apoptosis Induced by Chelerythrine in Osteosarcoma

Cell surface receptor expression patterns in osteosarcoma

The effect of bone morphogenetic protein-2 on osteosarcoma metastasis

Platelet‐derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma

Ganglioside GD2 as a therapeutic target for antibody‐mediated therapy in patients with osteosarcoma

Antigenic Evidence of Prevalence and Diversity of Mycobacterium tuberculosis Arabinomannan

β-Catenin Does Not Confer Tumorigenicity When Introduced into Partially Transformed Human Mesenchymal Stem Cells

HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival

Abstract 1418: Screening and identification of key surface markers of mesenchymal stem cell osteogenic differentiation and osteosarcoma development

Targeting Glycoprotein NMB With Antibody-Drug Conjugate, Glembatumumab Vedotin, for the Treatment of Osteosarcoma

Abstract 3984: Elucidating expression patterns of GPNMB and potential anti-tumor effects of the antibody-drug conjugate, glembatumumab vedotin (CDX-011) in human osteosarcoma primary samples and cell lines

Detection of circulating tumor DNA in patients with osteosarcoma

Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R)

Abstract 1630: Effects of rhBMP-2 on osteosarcoma tumorigenesis

Abstract 1412: Utilizing cell surface markers to define osteosarcoma and the stages of osteoblast differentiation

Abstract 4134: Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma

Abstract 697: Stage 1 in vivo evaluation of multi-receptor tyrosine-kinase inhibitor lenvatinib in osteosarcoma patient derived mouse xenograft models

Abstract 2731: Identifying circulating tumor DNA in patients with osteosarcoma

Abstract 1950: Introducing c-Myc into transformed human mesenchymal stem cells and osteoblasts to recapitulate the osteosarcoma phenotype

Abstract 920: ICAM-1(CD54) is involved in the osteogenic differentiation of mesenchymal stem cells and affects the progression of osteosarcoma cells

Abstract 1208: Elucidating possible functional implications of osteosarcoma risk-associated genetic level alterations in IGF2R

Suchergebnisse filtern